Enhanced Group Inc. Reports Third Quarter 2026 Results
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Definitive agreement signed to acquire ~
Stake in DEAG to be acquired via an all-stock transaction at 5.3x FY2027E Adjusted EBITDA(1)(3), with combined 2027E revenue expected at approximately
Concurrent
Third quarter revenue of
Third quarter Net Loss of
Third quarter Adjusted EBITDA(1)(2) loss of
Cash and cash equivalents of
Business & Operational Highlights
-
Executed exchange share agreements with a small group of DEAG shareholders to acquire a
77% controlling interest in DEAG. -
Concurrent with the DEAG exchange share agreements, executed a securities purchase agreement for a private placement to raise an additional
$15 million -
Successfully completed the “Enhanced Breakers 1” event, featuring Beatriz Pirón who, after having to withdraw from the inaugural Enhanced Games in
Las Vegas due to an injury, returned just six weeks later following a highly personalized recovery and enhancement protocol to set a new world record in the snatch - showcasing the power of personalized enhancements. -
“Enhanced Breakers 2” will take place on December 19, 2026 at the University of
Nevada ,Las Vegas , featuring eight swimmers, four men and four women, in a 25-meter short-course format. Enhanced Breakers events operate at a fraction of the cost of a flagship Enhanced Games event, yet provide massive visibility and fan engagement, particularly via social media. - Launched the beta version of “Enhanced OS” today. “Enhanced OS” is an AI-powered platform designed to combine medical records, biomarkers testing and wearable data into individualized health plans, with licensed physicians retaining clinical decision-making authority.
- Expanded its offerings to include Modafinil and six additional peptides, including BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax, through its Live Enhanced telehealth platform, supplementing its existing offerings of 12 Rx products. All peptides are available by prescription.
-
Amended the Rezolve sponsorship agreement on August 11, 2026 so that the commitment is a fixed dollar consideration of
$10.0 million -
Completed the third and final closing of its approximately
$50 million - Effected a one-for-ten reverse stock split, effective October 29, 2026.
-
Apeiron, Mr. Martin and other key shareholders voluntarily extended the lock-up on approximately 3.1 million Class A shares from six months to twelve months, as announced on November 2, 2026. This extension reduced the number of shares subject to the expiration of the original lock-up period on November 8, 2026 by
60% .
Maximilian Martin, Co-Founder and Chief Executive Officer of Enhanced, commented, “The third quarter was a deliberate breather between the inaugural Enhanced Games and the next growth acceleration. We used Q3 to refine our telehealth offering, bring Enhanced OS to beta, and entered into agreements to acquire a controlling interest in DEAG. With the acquisition of a majority stake in DEAG we are entering hyper-growth mode — not only by continuing to build the Enhanced Games franchise and the Live Enhanced telehealth business. Our goal going forward is to build, acquire, and invest in high-potential businesses globally spanning sports and live entertainment, as well as scalable commercialization platforms such as ticketing, direct-to-consumer brands, and beyond. We believe we are benefiting from powerful macro tailwinds: AI and robotics will increasingly reduce the need for human labor, giving humanity significantly more free time. We believe much of this additional leisure time will be spent on real-life, shared experiences — creating substantial opportunities in sports, entertainment, and live experiences. And we believe we are fully financed for growth.”
Sid Banthiya, Chief Financial Officer of Enhanced, stated, “Our third quarter demonstrates the operating discipline we committed to following the inaugural Enhanced Games. We have deliberately held back on aggressively scaling our telehealth platform so far, as we wanted to get the product mix right, optimize the unit economics and build something that offers more than just an online pharmacy. We have made significant progress, with important KPIs like average order values continuing to stay ahead of others in the telehealth space, and tripled marketing efficiencies.
With Enhanced OS — its beta going live today — we have developed an AI-powered platform designed to integrate medical records, offer biomarker testing, and wearable data integration into personalized health plans, with licensed physicians retaining full clinical decision-making authority.
All of that taken together, we believe we are now ready to shift into growth mode with our telehealth business towards the end of the year. Consequently, we expect telehealth revenues in 2027 to reach well into the double-digit millions.”
Important clarification regarding our share count and market capitalization:
Only our Class A shares represent economic ownership in the company. Class B shares carry voting rights only and do not represent any economic ownership. Some data providers still incorrectly conflate the two share classes, resulting in an overstated market capitalization on some platforms.
We have approximately 13.7 million Class A shares outstanding. Based on yesterday’s closing share price of
Upcoming share issuances:
- The acquisition of DEAG is expected to add approximately 11 million Class A shares upon closing, currently envisaged for Q1.
-
The
$15 million
Third Quarter 2026 Consolidated Results
General: For the foreseeable future, the sports franchise business will generate disproportionately high revenues in the quarter during which the annual Enhanced Games are held. As a result, quarter-on-quarter comparisons may be less meaningful.
Once the DEAG acquisition closes, expected in Q1 2027, we will move to full segment reporting to give investors a clear view of all three platforms - sports, telehealth and live entertainment — and make quarter-to-quarter performance easier to track.
For the three months ended September 30, 2026, unless otherwise specified:
Revenue was
Games, athletes and event operating costs were
For the 2027 Enhanced Games, the Company targets a budget of approximately
Selling, general and administrative expenses were
Loss from operations was
Net loss in the third quarter was
Adjusted EBITDA(1)(2) was a loss of
Cash and cash equivalents were
DEAG Transaction
As previously announced on November 5, 2026, Enhanced entered into definitive exchange agreements with certain shareholders of DEAG, a
Following the closing of the transaction, the combined group is expected to generate approximately
The transaction is all-stock, with no cash consideration. Enhanced expects to issue approximately 11 million shares of Class A common stock at
For more information on the transaction please refer to the materials uploaded on Enhanced’s Investor Relations Website as well as filed with the SEC.
PIPE Financing
In connection with the DEAG acquisition, Enhanced entered into a securities purchase agreement with institutional and accredited investors for a private investment in public equity (“PIPE”) financing of
The PIPE is intended to provide additional capital to support Enhanced's growth strategy, including the further acceleration of its existing sporting business, telehealth and performance products businesses, as well as supporting DEAG’s buy-and-build strategy and general corporate purposes. It is expected to close concurrently with the DEAG acquisition, subject to customary closing conditions.
Notes
(1) Adjusted EBITDA is a non-GAAP financial measure. The definition of Adjusted EBITDA can be found in the Non-GAAP Financial Measures section of this release. A reconciliation of net loss to Adjusted EBITDA for the three and nine months ended September 30, 2026 and 2025 can be found in the Supplemental Information in this release.
(2) A reconciliation of net loss to Adjusted EBITDA for the three and nine months ended September 30, 2026 and 2025 can be found in the Supplemental Information in this release.
(3) “Adjusted EBITDA” means EBITDA provided on a lease-adjusted basis, under which operating lease cost (right-of-use asset depreciation and lease interest) recognized by DEAG under International Financial Reporting Standards (“IFRS”) 16 is deducted from EBITDA to approximate a
Non-GAAP Financial Measures
The Company refers to certain financial measures that are not recognized under
The Company defines Adjusted EBITDA as net loss excluding income taxes, net interest expense, depreciation and amortization, equity-based compensation, transaction costs, certain legal costs, restructuring and severance charges, and certain other items when applicable.
Enhanced management believes Adjusted EBITDA is useful to investors because it eliminates the significant level of non-cash and non-recurring items, including stock-based compensation and the one-time transaction cost associated with the Business Combination that affect period-over-period comparability.
Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Some of these limitations are:
- It does not reflect every cash expenditure, future requirements for capital expenditures, or contractual commitments;
- It does not reflect interest expense or the cash requirements necessary to service interest or principal payments on the Company’s obligations;
- Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced or require improvements in the future, and Adjusted EBITDA does not reflect any cash requirement for such replacements or improvements;
- Equity-based compensation is a recurring component of the Company’s compensation programs, and excluding it does not reflect the full cost of retaining personnel; and
- It is not adjusted for all non-cash income or expense items reflected in the Company’s statements of cash flows.
The Company defines Live Enhanced gross revenue as the total amount billed to customers for Live Enhanced products, before deducting the amounts retained by the third-party telehealth providers that deliver the prescription services.
The Company defines performance marketing spend as cash spend on digital advertising platforms to acquire Live Enhanced customers. It excludes non-cash advertising credits received as sponsorship consideration and agency, creative and consulting costs.
These Non-GAAP measures should not be considered a substitute for the reported results prepared in accordance with GAAP and should not be considered in isolation or as an alternative to net loss as an indicator of the Company’s financial performance, as a measure of discretionary cash available to invest in the growth of its business, or as a measure of cash that will be available to meet its obligations. This non-GAAP financial measure, as determined and presented by the Company, may not be comparable to related or similarly titled measures reported by other companies.
Additional Information
The Company will host a conference call at 4:30 pm ET on November 12, 2026 to discuss its third quarter 2026 results. All interested parties are welcome to listen to a live webcast hosted through the Company’s website at investors.enhanced.com.
Any accompanying materials referenced during the call will be made available on November 12, 2026 at investors.enhanced.com. A replay of the call will be available shortly after the conference call concludes and can be accessed on the Company’s investor website.
Website and Social Media Disclosure
Investors and others should note that Enhanced announces material financial and operational information to its investors using press releases, SEC filings and public conference calls and webcasts, as well as its investor relations site at investors.enhanced.com. Enhanced may also use its website and/or social media outlets, such as LinkedIn, Instagram, TikTok, YouTube, Facebook, and X, as distribution channels of material information about the Company. Financial and other information regarding Enhanced is routinely posted on and accessible through the company’s LinkedIn page at https://www.linkedin.com/company/enhanced-games/, its Instagram page at https://www.instagram.com/enhanced_games/, its TikTok page at https://www.tiktok.com/@enhanced_games, its YouTube page at https://www.youtube.com/@enhanced_games1, its Facebook page at https://www.facebook.com/enhancedgames1/, and its X page at https://x.com/enhanced_games. In addition, you may automatically receive email alerts and other information about Enhanced by enrolling your email address on the investor relations section of the Company’s website.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company’s business strategy and plans, future events and event economics, anticipated sponsorship, media rights and other revenue opportunities, the development and monetization of its direct-to-consumer and telehealth platforms, potential acquisitions and partnerships, expectations regarding the regulatory environment, liquidity and capital resources, and anticipated financial and operational performance. The words “believe,” “may,” “will,” “estimate,” “potential,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “target,” and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions.
These forward-looking statements are based on management’s current expectations. These statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: the Company’s limited operating history and history of operating losses; the Company’s need for additional capital and its ability to obtain financing on acceptable terms or at all; the Company’s ability to stage future events profitably and to secure sponsorship, media rights, ticketing and hospitality revenue on anticipated terms; the Company’s dependence on athlete, clinician, scientific and commercial partners willing to participate in a novel and publicly scrutinized model; changes in, or the Company’s failure to comply with, laws and regulations applicable to performance-enhancing substances, peptides, compounded products, telehealth and direct-to-consumer healthcare; adverse publicity, litigation or regulatory action concerning the Company, its events, its products or its key personnel; risks relating to athlete health and safety and the Company’s medical and clinical protocols; competition in the telehealth, supplement and performance medicine markets, including pricing pressure; the Company’s ability to build consumer and clinician trust and to develop the data capabilities described in this release; the Company’s ability to identify, complete and integrate acquisitions and partnerships; risks relating to conducting operations and clinical activities in international jurisdictions, including geopolitical instability; the Company’s dependence on the continued services of executive management and other key personnel; risks relating to the Company’s recent business combination and status as a newly public company, including its ability to remediate existing material weaknesses and implement and maintain an effective system of internal controls over financial reporting; and other important factors discussed and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date they are made and, except as may be required under applicable law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
About Enhanced Group, Inc.
Enhanced Group, Inc. (NYSE: ENHA) is a performance medicine and sports company. Enhanced operates the Enhanced Games, the first global sporting competition conducted under medically supervised performance enhancement protocols, and the Enhanced Breakers series. Through Live Enhanced, its direct-to-consumer platform, the Company offers personalized performance products and is building a personalized performance telehealth business informed by data generated in its Institutional Review Board-approved clinical trial. Enhanced’s mission is to expand access to medically supervised performance optimization for athletes and non-athletes alike.
Enhanced Ltd Condensed Consolidated Balance Sheets (Unaudited) |
|||||||
|
September 30, 2026 |
|
December 31, 2025 |
||||
ASSETS |
|
|
|
||||
CURRENT ASSETS: |
|
|
|
||||
Cash and cash equivalents |
$ |
12,070,116 |
|
|
$ |
25,253,578 |
|
Marketable Securities |
|
8,097,015 |
|
|
|
— |
|
Deposit assets |
|
— |
|
|
|
597,011 |
|
Deferred offering costs |
|
— |
|
|
|
3,987,901 |
|
Other receivables |
|
2,252,985 |
|
|
|
1,000 |
|
Contract asset |
|
3,116,073 |
|
|
|
— |
|
Prepaid expenses and other assets |
|
1,803,939 |
|
|
|
435,750 |
|
Total current assets |
|
27,340,128 |
|
|
|
30,275,240 |
|
OTHER ASSETS: |
|
|
|
||||
Deposit assets, long-term |
|
— |
|
|
|
1,360,004 |
|
Equipment, net |
|
7,540,410 |
|
|
|
433,804 |
|
Intangible assets, net |
|
30,000 |
|
|
|
30,000 |
|
TOTAL ASSETS |
$ |
34,910,538 |
|
|
$ |
32,099,048 |
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
|
|
|
||||
CURRENT LIABILITIES: |
|
|
|
||||
Simple Agreements for Future Equity |
$ |
— |
|
|
$ |
29,660,667 |
|
Accounts payable and accrued expenses |
|
25,357,023 |
|
|
|
2,991,524 |
|
Deposit liabilities |
|
— |
|
|
|
476,253 |
|
Other current liabilities |
|
235,103 |
|
|
|
18,896 |
|
Total liabilities |
|
25,592,126 |
|
|
|
33,147,340 |
|
Commitments and contingencies (Note 12) |
|
|
|
||||
STOCKHOLDERS' EQUITY (DEFICIT): |
|
|
|
||||
Class A Common Stock, |
|
1,372 |
|
|
|
1,080 |
|
Class B Common Stock, |
|
2,588 |
|
|
|
— |
|
Additional paid-in capital |
|
133,192,202 |
|
|
|
30,991,404 |
|
Accumulated deficit |
|
(123,877,750 |
) |
|
|
(32,040,776 |
) |
Total stockholders' equity (deficit) |
|
9,318,412 |
|
|
|
(1,048,292 |
) |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
34,910,538 |
|
|
$ |
32,099,048 |
|
|
|
|
|
||||
|
|
|
|
||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements |
Enhanced Ltd Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) |
|||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||
|
September 30, 2026 |
|
September 30, 2025 |
|
September 30, 2026 |
|
September 30, 2025 |
||||||||
Revenue |
$ |
3,307,433 |
|
|
$ |
— |
|
|
$ |
21,010,367 |
|
|
$ |
— |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Games, athletes and event operating costs |
|
2,673,525 |
|
|
|
1,312,291 |
|
|
|
62,392,583 |
|
|
|
3,055,241 |
|
Selling, general and administrative expenses |
|
12,731,030 |
|
|
|
4,171,161 |
|
|
|
36,571,595 |
|
|
|
8,559,989 |
|
Transaction expenses |
|
1,180,306 |
|
|
|
479,242 |
|
|
|
13,702,673 |
|
|
|
799,398 |
|
Depreciation |
|
212,410 |
|
|
|
2,418 |
|
|
|
298,278 |
|
|
|
3,611 |
|
Total operating expenses |
|
16,797,271 |
|
|
|
5,965,112 |
|
|
|
112,965,129 |
|
|
|
12,418,239 |
|
Loss from operations |
|
(13,489,838 |
) |
|
|
(5,965,112 |
) |
|
|
(91,954,762 |
) |
|
|
(12,418,239 |
) |
Other income: |
|
|
|
|
|
|
|
||||||||
Interest income and other expense, net |
|
27,192 |
|
|
|
34,432 |
|
|
|
117,786 |
|
|
|
168,306 |
|
Total other income, net |
|
27,192 |
|
|
|
34,432 |
|
|
|
117,786 |
|
|
|
168,306 |
|
Loss before income taxes |
|
(13,462,646 |
) |
|
|
(5,930,680 |
) |
|
|
(91,836,976 |
) |
|
|
(12,249,933 |
) |
Net loss and comprehensive loss |
$ |
(13,462,646 |
) |
|
$ |
(5,930,680 |
) |
|
$ |
(91,836,976 |
) |
|
$ |
(12,249,933 |
) |
Net loss per share, basic and diluted |
$ |
(1.01 |
) |
|
$ |
(0.58 |
) |
|
$ |
(7.66 |
) |
|
$ |
(1.21 |
) |
Weighted-average shares of common stock, basic and diluted |
|
13,378,513 |
|
|
|
10,313,354 |
|
|
|
11,988,798 |
|
|
|
10,137,803 |
|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements |
Enhanced Ltd Condensed Consolidated Statements of Cash Flows (Unaudited) |
|||||||
|
Nine Months Ended |
||||||
|
September 30, 2026 |
|
September 30, 2025 |
||||
Operating Activities |
|
|
|
||||
Net loss |
$ |
(91,836,976 |
) |
|
$ |
(12,249,933 |
) |
Adjustments to reconcile net loss to net cash used in operating activities |
|
|
|
||||
Stock-based compensation expense |
|
11,050,296 |
|
|
|
— |
|
Non-cash marketing expense credits |
|
7,090,000 |
|
|
|
— |
|
Non-cash sponsorship revenue |
|
(20,091,073 |
) |
|
|
— |
|
Deferred offering cost write off |
|
4,052,804 |
|
|
|
— |
|
Shares issued for services in Business Combination and Games events |
|
2,519,760 |
|
|
|
— |
|
Depreciation expense |
|
298,278 |
|
|
|
3,611 |
|
Changes in operating assets and liabilities |
|
|
|
||||
Accounts payable and accrued expenses |
|
17,088,991 |
|
|
|
1,535,533 |
|
Deposit liabilities |
|
(476,253 |
) |
|
|
442,011 |
|
Other current liabilities |
|
216,207 |
|
|
|
22,405 |
|
Deposit assets |
|
1,957,015 |
|
|
|
(1,153,252 |
) |
Other receivable |
|
(350,000 |
) |
|
|
— |
|
Prepaid expenses and other current assets |
|
(1,482,189 |
) |
|
|
(13,140 |
) |
Net cash used in operating activities |
|
(69,963,140 |
) |
|
|
(11,412,765 |
) |
Investing Activities |
|
|
|
||||
Purchases of equipment |
|
(5,372,921 |
) |
|
|
(76,549 |
) |
Capitalized internal use software |
|
(2,031,963 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(7,404,884 |
) |
|
|
(76,549 |
) |
Financing Activities |
|
|
|
||||
Proceeds from issuance of Simple Agreements for Future Equity |
|
10,341,342 |
|
|
|
— |
|
Proceeds from issuance of preferred stock and warrants |
|
— |
|
|
|
10,711,743 |
|
Proceeds from exercise of stock option and warrants |
|
1,901,406 |
|
|
|
2,333 |
|
Proceeds from SPAC transaction |
|
3,038,332 |
|
|
|
— |
|
Proceeds from issuance of Private Placement |
|
49,999,990 |
|
|
|
— |
|
Stock-subscription deposit of Private Placement |
|
|
|
— |
|
||
Proceeds from working capital note |
|
11,750,000 |
|
|
|
— |
|
Principal repayment of working capital note |
|
(11,750,000 |
) |
|
|
— |
|
Payment of offering costs |
|
(1,096,508 |
) |
|
|
— |
|
Net cash provided by financing activities |
|
64,184,562 |
|
|
|
10,714,076 |
|
Decrease in cash and cash equivalents |
|
(13,183,462 |
) |
|
|
(775,238 |
) |
Cash and cash equivalents, at beginning of period |
|
25,253,578 |
|
|
|
4,018,226 |
|
Cash and cash equivalents, at end of period |
$ |
12,070,116 |
|
|
$ |
3,242,988 |
|
|
|
|
|
||||
Supplemental disclosures of non-cash activities: |
|
|
|
||||
Conversion of Simple Agreements for Future Equity to common stock |
|
40,002,009 |
|
|
|
— |
|
Offering costs included in accounts payable and accrued expenses |
|
5,276,507 |
|
|
|
— |
|
Utilization of marketing expense credits in prepaid and other current assets |
|
7,090,000 |
|
|
|
— |
|
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements |
Non-GAAP Financial Measures
Reconciliation of Net Loss to Adjusted EBITDA |
|||||||||||||||||||
|
Three Months Ended |
|
Nine Months Ended |
||||||||||||||||
|
September 30, 2026 |
|
June 30, 2026 |
|
September 30, 2025 |
|
September 30, 2026 |
|
September 30, 2025 |
||||||||||
Reconciliation of Net Loss to Adjusted EBITDA |
|
|
|
|
|
|
|
|
|
||||||||||
Net loss |
$ |
(13,462,646 |
) |
|
$ |
(61,944,898 |
) |
|
$ |
(5,930,680 |
) |
|
$ |
(91,836,976 |
) |
|
$ |
(12,249,933 |
) |
Interest income, net |
|
(8,359 |
) |
|
|
39,101 |
|
|
|
(34,432 |
) |
|
|
(104,436 |
) |
|
|
(145,448 |
) |
Depreciation |
|
212,410 |
|
|
|
69,207 |
|
|
|
2,418 |
|
|
|
298,278 |
|
|
|
3,611 |
|
Equity-based compensation expense (1) |
|
2,538,420 |
|
|
|
7,784,404 |
|
|
|
— |
|
|
|
11,050,296 |
|
|
|
— |
|
Transaction costs (2) |
|
1,180,306 |
|
|
|
10,877,007 |
|
|
|
479,242 |
|
|
|
13,702,673 |
|
|
|
799,398 |
|
Certain legal costs (3) |
|
— |
|
|
|
193,140 |
|
|
|
1,641,724 |
|
|
|
733,456 |
|
|
|
1,933,590 |
|
Restructuring and severance (4) |
|
278,494 |
|
|
|
276,667 |
|
|
|
— |
|
|
|
652,493 |
|
|
|
— |
|
Other adjustments (5) |
|
460,945 |
|
|
|
(17,816 |
) |
|
|
— |
|
|
|
466,428 |
|
|
|
(22,858 |
) |
Total Adjusted EBITDA |
$ |
(8,800,430 |
) |
|
$ |
(42,723,188 |
) |
|
$ |
(3,841,728 |
) |
|
$ |
(65,037,788 |
) |
|
$ |
(9,681,640 |
) |
Net loss margin |
|
(407.0 |
)% |
|
|
(350.0 |
)% |
|
|
n/a |
|
|
|
(437.1 |
)% |
|
|
n/a |
|
Adjusted EBITDA margin |
|
(266.1 |
)% |
|
|
(241.4 |
)% |
|
|
n/a |
|
|
|
(309.6 |
)% |
|
|
n/a |
|
| The Company began presenting Adjusted EBITDA in connection with the Business Combination and its NYSE listing | |
|
|
| (1) Equity-based compensation expense consists of employee and non-employee stock-based compensation. | |
| (2) Transaction costs consist of offering costs, banking and investor relations fees, other consulting, legal fees, and accounting and tax fees incurred in connection with the Business Combination and related financing activities. | |
| (3) Certain legal costs for trademark and SEC filings along with executive immigration fees. | |
| (4) Restructuring and severance consists of severance costs. | |
| (5) Other adjustments consist of certain non-operating items, including changes in the fair value of SAFEs, unrealized and realized gains and losses, and other miscellaneous items. | |
View source version on businesswire.com: https://www.businesswire.com/news/home/20261112283172/en/
Investor Contact
zaia.lawandow@enhanced.org
enhanced@icrinc.com
Media Contact
media@enhanced.com
Source: Enhanced Group Inc.